<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-1149</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕТАБОЛИЧЕСКИЕ НАРУШЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>МЕТАБОЛИЧЕСКИЕ НАРУШЕНИЯ</subject></subj-group></article-categories><title-group><article-title>Особенности сна при ожирении</article-title><trans-title-group xml:lang="en"><trans-title>Sleep characteristics in obesity</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Любшина</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lubshina</surname><given-names>O. V.</given-names></name></name-alternatives><email xlink:type="simple">kafedrakf@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Верткин</surname><given-names>А. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Vertkin</surname><given-names>A. L.</given-names></name></name-alternatives><email xlink:type="simple">kafedrakf@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Левин</surname><given-names>Я. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Levin</surname><given-names>Ya. I.</given-names></name></name-alternatives><email xlink:type="simple">kafedrakf@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Московский государственный медико-стоматологический университет</institution></aff><aff xml:lang="en"><institution>Moscow State Medico-Stomatological University</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГКБ № 81, Москва</institution></aff><aff xml:lang="en"><institution>City Clinical Hospital № 81, Moscow</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>20</day><month>02</month><year>2007</year></pub-date><volume>6</volume><issue>1</issue><fpage>73</fpage><lpage>78</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Любшина О.В., Верткин А.Л., Левин Я.И., 2007</copyright-statement><copyright-year>2007</copyright-year><copyright-holder xml:lang="ru">Любшина О.В., Верткин А.Л., Левин Я.И.</copyright-holder><copyright-holder xml:lang="en">Lubshina O.V., Vertkin A.L., Levin Y.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/1149">https://cardiovascular.elpub.ru/jour/article/view/1149</self-uri><abstract><p>Цель. Изучить роль нарушения сна в формировании клинических проявлений ожирения у больных без коморбидной патологии. Материал и методы. В исследование были включены 66 больных ожирением без коморбидной патологии и 24 здоровых добровольцев. Все больные проходили подробное клиническое обследование. Использовались психометрические шкалы субъективной самооценки: анкета субъективной оценки нарушений сна; госпитальная шкала тревоги и депрессии; анкета определения вегетативных расстройств. Сомнологическая функция оценивалась полиграфическим методом. Результаты. Патология сна при ожирении наблюдалась у 86% больных. 59% составили больные с дыхательными расстройствами (ДР) во время сна и типичными для подобных нарушений жалобами: плохое качество утреннего пробуждения, утренние головные боли, дневная сонливость. Функция засыпания, непрерывность сна и общая длительность сна у таких больных не страдали, однако отмечался дефицит глубоких стадий медленноволнового сна (стадии 3 и 4) и фазы быстрого сна (ФБС). У 27% больных ДР во сне отсутствовали, наиболее распространенной была жалоба на раннее пробуждение. Объективно отмечались снижение общего времени сна, увеличение времени засыпания и бодрствования внутри сна, нарушение всей структуры сна в основном за счет частых пробуждений, снижение представленности глубоких стадий медленноволнового сна и ФБС. 14% больных не имели выраженных субъективных и объективных изменений качества сна. Заключение. В комплексном лечении ожирения значительное внимание следует уделять дифференцированной коррекции патологии сна, включающей при необходимости лечение ДР и адекватную терапию психопатологических состояний.</p></abstract><trans-abstract xml:lang="en"><p>Aim. To study sleep disturbance role in obesity pathogenesis among co-morbidity-free patients. Material and methods. The study included 66 co-morbidity-free obese patients and 24 healthy volunteers. All participants underwent detailed clinical examination. Psychometrical scales for subjective self-assessment were used: subjective sleep disturbance assessment scale, hospital anxiety and depression scale; vegetative disturbance scale. Somnological function was assessed by polysomnography method. Results. Sleep pathology in obesity was registered in 86% of the patients, including 59% with sleep respiratory disturbances (RD) and typical complaints: poor quality of morning wake-up, morning headache, daytime somnolence. Falling asleep process, sleep continuity, and total sleep length were unchanged, but deep stages of slow-wave sleep (stages 3 and 4) and fast sleep phase (FSP) were deficient. In 27% of the patients, sleep RD were absent, with premature wake-ups as a typical complaint. Objectively, total sleep time reduction, falling asleep and intra-sleep vigilance time increase, sleep structure disturbance, mostly due to frequent wake-ups, decrease of deep stage slow-wave sleep and FSP were observed. No subjective or objective sleep quality disturbances were registered in 14% of the patients. Conclusion. In complex obesity treatment, differential sleep pathology correction is important, including RD management and adequate psycho-pathology therapy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ожирение</kwd><kwd>нарушение сна</kwd><kwd>фазы сна</kwd><kwd>полисомнография</kwd></kwd-group><kwd-group xml:lang="en"><kwd>obesity</kwd><kwd>sleep disturbance</kwd><kwd>sleep phases</kwd><kwd>polysomnography</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бутрова С.А. Сибутрамин (Меридиа) в лечении ожирения: опыт применения в России, Клин фармак тер 2001; 10(2): 55-8.</mixed-citation><mixed-citation xml:lang="en">Бутрова С.А. Сибутрамин (Меридиа) в лечении ожирения: опыт применения в России, Клин фармак тер 2001; 10(2): 55-8.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Левин Я.И., Посохов С.И., Ханунов И.Г. Ночной сон и депрессия. Соврем психиат 1998; 3: 23 c.</mixed-citation><mixed-citation xml:lang="en">Левин Я.И., Посохов С.И., Ханунов И.Г. Ночной сон и депрессия. Соврем психиат 1998; 3: 23 c.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Полуэктов М.Г. Ожирение и сон. В кн.: Ожирение. Под ред. И.И.Дедова, Г.А.Мельниченко. Москва «Медицинское информ агентство» 2001; 272-312.</mixed-citation><mixed-citation xml:lang="en">Полуэктов М.Г. Ожирение и сон. В кн.: Ожирение. Под ред. И.И.Дедова, Г.А.Мельниченко. Москва «Медицинское информ агентство» 2001; 272-312.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bitz C, Helle H, A Astrup. A Paradoxical Diurnal Movement Pattern in Obese Subjects With Type 2 Diabetes. Diabetes Care 2005; 28: 2040-1.</mixed-citation><mixed-citation xml:lang="en">Bitz C, Helle H, A Astrup. A Paradoxical Diurnal Movement Pattern in Obese Subjects With Type 2 Diabetes. Diabetes Care 2005; 28: 2040-1.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bliwise D, Feldman D, Bliwise N, et al. Risk factors for sleepdisordered breathing in heterogeneous geriatric populations. Am J Geriatr Society 1987; 35: 132-41.</mixed-citation><mixed-citation xml:lang="en">Bliwise D, Feldman D, Bliwise N, et al. Risk factors for sleepdisordered breathing in heterogeneous geriatric populations. Am J Geriatr Society 1987; 35: 132-41.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cooper BG, White J, Ashworth LA, et al. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 1995; 18(3): 172-9.</mixed-citation><mixed-citation xml:lang="en">Cooper BG, White J, Ashworth LA, et al. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 1995; 18(3): 172-9.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Drenick EJ, Bales GS. Excessive mortality and causes of death in morbidly obese men. JAVA 1980; 243: 443-5.</mixed-citation><mixed-citation xml:lang="en">Drenick EJ, Bales GS. Excessive mortality and causes of death in morbidly obese men. JAVA 1980; 243: 443-5.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Grunstein RR. Metabolic aspects of sleep apnea. Sleep 1996; 19(10): 218-20.</mixed-citation><mixed-citation xml:lang="en">Grunstein RR. Metabolic aspects of sleep apnea. Sleep 1996; 19(10): 218-20.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Grunstein RR, Handelsman DJ, Lawrence SJ, et al. Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. J Clin Endocrinol Metab 1989; 68: 352-8.</mixed-citation><mixed-citation xml:lang="en">Grunstein RR, Handelsman DJ, Lawrence SJ, et al. Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. J Clin Endocrinol Metab 1989; 68: 352-8.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Guilleminault C. Upper Airway Resistance Syndrome, Insomnia, and Functional Somatic Syndromes. Chest 2003; 123: 12-4.</mixed-citation><mixed-citation xml:lang="en">Guilleminault C. Upper Airway Resistance Syndrome, Insomnia, and Functional Somatic Syndromes. Chest 2003; 123: 12-4.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lugaresi E, Cirignotta E, Montagna P, Sforza E. Snoring: pathogenic, clinical and therapeutic aspects. In: Principles and Practice of Sleep Medicine: 2nd ed. Philadelphia: Harcourt Brace &amp; Company 1994; 621-9.</mixed-citation><mixed-citation xml:lang="en">Lugaresi E, Cirignotta E, Montagna P, Sforza E. Snoring: pathogenic, clinical and therapeutic aspects. In: Principles and Practice of Sleep Medicine: 2nd ed. Philadelphia: Harcourt Brace &amp; Company 1994; 621-9.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Redwine L, Hauger RL, Gillin СJ, Irwin M. Effects of sleep and sleep deprivation in interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J Clin Endocrinol Metab 2000; 85: 3597-603.</mixed-citation><mixed-citation xml:lang="en">Redwine L, Hauger RL, Gillin СJ, Irwin M. Effects of sleep and sleep deprivation in interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J Clin Endocrinol Metab 2000; 85: 3597-603.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Saini J, Krieger J, Brandenberger G, et al. Continuous positive airway pressure treatment: Effects on grouth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm Metab Res 1993; 25: 375-81.</mixed-citation><mixed-citation xml:lang="en">Saini J, Krieger J, Brandenberger G, et al. Continuous positive airway pressure treatment: Effects on grouth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm Metab Res 1993; 25: 375-81.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Seidell JS. The worldwide epidemic of obesity. In: Progress in obesity research. 8-th International cjngress of obesity. B.Guy-Grand, G.Ailhaud. eds London. 1999; 47-53.</mixed-citation><mixed-citation xml:lang="en">Seidell JS. The worldwide epidemic of obesity. In: Progress in obesity research. 8-th International cjngress of obesity. B.Guy-Grand, G.Ailhaud. eds London. 1999; 47-53.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Spiegel K, Leproult R, Van Cauter E: Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354: 1435-9.</mixed-citation><mixed-citation xml:lang="en">Spiegel K, Leproult R, Van Cauter E: Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354: 1435-9.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Veldhuis JD, Iranmanesh A. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function and sleep. Sleep 1996; 19: 221-4.</mixed-citation><mixed-citation xml:lang="en">Veldhuis JD, Iranmanesh A. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function and sleep. Sleep 1996; 19: 221-4.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
